Historical award
Microbiotix, Inc.
This record is historical buying context, not open work.
How current is this award history?
Fiscal year 2025: data through (27 days old).
Fiscal year 2026: data through (27 days old).
Official release availability details
Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
- Current award value
- $2,594,319.91
- Potential award value
- $2,594,319.91
- Total obligated to date
- $2,554,223.54
Source date: Oct 14, 2026
Recorded work
DEVELOP NOVEL AND INNOVATIVE SMALL MOLECULE THERAPEUTICS TO TREAT (POST-EXPOSURE THERAPEUTIC) INFECTIONS BY BOTH FILOVIRUS FAMILY MEMBERS (EBOLA VIRUSES AND MARBURG VIRUSES).
Award activity
- Obligations in covered fiscal years
- −$40,096.37
- Transactions in covered fiscal years
- 1
Award value and obligated funds describe different amounts. Review the official record for the full transaction history.
Record identifier
CONT_AWD_HDTRA118C0001_9700_-NONE-_-NONE-